相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2023)
The effectiveness of AGV, Ex-PRESS, or trabeculectomy in the treatment of primary and secondary glaucoma: a systematic review and network meta-analysis
Xiwen Zhang et al.
ANNALS OF PALLIATIVE MEDICINE (2022)
Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension Start Early, Dose High, Combine
Johannes M. Douwes et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)
Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial
Christine M. Pierce et al.
JOURNAL OF PEDIATRICS (2021)
The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
Tingting Shu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Effect of Sildenafil on Mortality in Term Neonates with Hypoxemic Respiratory Failure due to Persistent Pulmonary Hypertension (SIPHON) - A Randomised Control Trial
Deepti Thandaveshwara et al.
Journal of Nepal Paediatric Society (2021)
Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis
Wenhai Fu et al.
DRUG DELIVERY (2021)
Endothelin receptor antagonists for pulmonary arterial hypertension
Chao Liu et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Update on pediatric pulmonary arterial hypertension
Dunbar Ivy et al.
CURRENT OPINION IN CARDIOLOGY (2021)
The Effect of Perioperative Administration of Treprostinil in Infants with Non-restrictive Ventricular Septal Defect and Severe Pulmonary Arterial Hypertension
Shu-Ting Huang et al.
PEDIATRIC CARDIOLOGY (2020)
Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials
Qingyou Zhang et al.
CARDIOLOGY IN THE YOUNG (2020)
Benefits of perioperative sildenafil therapy in children with a ventricular septal defect with pulmonary artery hypertension on early surgical outcomes
Ruchit Patel et al.
JOURNAL OF CARDIAC SURGERY (2020)
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial
Mamdouh El-Ghandour et al.
PEDIATRIC DRUGS (2020)
Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response
Joseph B. Tella et al.
PULMONARY CIRCULATION (2020)
Comparison of the effects of bosentan and sildenafil in the treatment of persistent pulmonary arterial hypertension in infants
Saba Farhangdoust et al.
JOURNAL OF CLINICAL NEONATOLOGY (2020)
Effectiveness and short-term survival associated with adding sildenafil to conventional therapy in the management of children with pulmonary hypertension
Martina B. William et al.
PROGRESS IN PEDIATRIC CARDIOLOGY (2020)
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
Georg Hansmann et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Erika B. Rosenzweig et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Sildenafil Use in Children with Pulmonary Hypertension
Jennifer L. Cohen et al.
JOURNAL OF PEDIATRICS (2019)
The Efficacy and Safety of Aerosolized Iloprost in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Hongyu Kuang et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
Prostacyclin for pulmonary arterial hypertension
Hayley Barnes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis
Xinwang Chen et al.
CLINICAL RESPIRATORY JOURNAL (2018)
The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis
Hong-Yu Kuang et al.
MEDICINE (2018)
Right ventricular function mirrors clinical improvement with use of prostacyclin analogues in pediatric pulmonary hypertension
Rachel K. Hopper et al.
PULMONARY CIRCULATION (2018)
Pulmonary Hypertension in Infants, Children, and Young Adults
Georg Hansmann
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population
Lin Li et al.
PULMONARY CIRCULATION (2017)
Sildenafil for pulmonary hypertension in neonates
Lauren E. Kelly et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects
Hamid Bigdelian et al.
JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH (2017)
Perioperative sildenafil therapy for children with ventricular septal defects and associated pulmonary hypertension undergoing corrective surgery: A randomised clinical trial
Sidharth Bhasin et al.
INDIAN JOURNAL OF ANAESTHESIA (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery
Ismihan Selen Onan et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2016)
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion
Rolf M. F. Berger et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial
Robin H. Steinhorn et al.
JOURNAL OF PEDIATRICS (2016)
Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta-Analysis of 4894 Patients From 24 Randomized Double-Blind Placebo-Controlled Clinical Trials
Anhua Wei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants
Kiran More et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Pediatric Pulmonary Hypertension Guidelines From the American Heart Association and American Thoracic Society
Steven H. Abman et al.
CIRCULATION (2015)
First experience with sildenafil after Fontan operation: short-term outcomes
Raffaele Giordano et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Sildenafil in pediatric pulmonary arterial hypertension
A. K. Dhariwal et al.
JOURNAL OF POSTGRADUATE MEDICINE (2015)
Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease
Zhuoming Xu et al.
PEDIATRIC PULMONOLOGY (2015)
Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children - A prospective randomized study
Vipul Krishen Sharma et al.
ANNALS OF CARDIAC ANAESTHESIA (2015)
Assessing Pulmonary Hypertensive Vascular Disease in Childhood
M. J. del Cerro Marin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
STARTS-2 Long-Term Survival With Oral Sildenafil Monotherapy in Treatment- Naive Pediatric Pulmonary Arterial Hypertension
Robyn J. Barst et al.
CIRCULATION (2014)
Oral Sildenafil and Inhaled Iloprost in the Treatment of Pulmonary Hypertension of the Newborn
Hasan Kahveci et al.
PEDIATRIC PULMONOLOGY (2014)
Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
Dina J. Ferdman et al.
PEDIATRICS (2014)
Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: A systematic review
Rong-chun Wang et al.
RESPIRATORY MEDICINE (2014)
Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension
Young Ho Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2013)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Robyn J. Barst et al.
CIRCULATION (2012)
A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn
W. A. Mohamed et al.
JOURNAL OF PERINATOLOGY (2012)
Pediatric Pulmonary Hypertension in the Netherlands Epidemiology and Characterization During the Period 1991 to 2005
Rosa Laura E. van Loon et al.
CIRCULATION (2011)
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
A. A. Hislop et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
A Comparison of Magnesium Sulphate and Sildenafil in the Treatment of the Newborns with Persistent Pulmonary Hypertension: A Randomized Controlled Trial
Sinan Uslu et al.
JOURNAL OF TROPICAL PEDIATRICS (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Use of Sildenafil in Persistent Pulmonary Hypertension of the Newborn
Arturo Vargas-Origel et al.
AMERICAN JOURNAL OF PERINATOLOGY (2010)
Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
Maurice Beghetti
CURRENT VASCULAR PHARMACOLOGY (2009)
Additional effects of bosentan in patients with idiopathic pulmonary arterial hypertension already treated with high-dose epoprostenol
Satoshi Akagi et al.
CIRCULATION JOURNAL (2008)
Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension
A. K. Doran et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children
Poongundran Namachivayam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Response to bosentan in children with pulmonary hypertension
S Maiya et al.
HEART (2006)
Effects of long-term bosentan in children with pulmonary arterial hypertension
EB Rosenzweig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells
B Tantini et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
RJ Barst et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Effect of beraprost sodium on pulmonaryvascular resistance in candidates for a Fontan procedure: A preliminary study
K Takahashi et al.
PEDIATRICS INTERNATIONAL (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
